These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2609240)

  • 1. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.
    Saeki S; Yamamura K; Matsushita M; Nishikimi N; Sakurai T; Nimura Y
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):525-9. PubMed ID: 9799055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous prostaglandin E1 in the treatment of venous ulcers--a double-blind, placebo-controlled trial.
    Rudofsky G
    Vasa Suppl; 1989; 28():39-43. PubMed ID: 2692199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of prostaglandin E1 on extravascular lung water in patients with severe heart failure].
    Lenz K; Kranz A; Kramer L; Buder R; Schollmayer E
    Wien Klin Wochenschr; 1996; 108(16):505-9. PubMed ID: 8967094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.
    Weiss C; Regele S; Velich T; Bärtsch P; Weiss T
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):271-7. PubMed ID: 11090253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary blood cell velocity in periulcerous regions of the lower leg measured by laser Doppler anemometry.
    Stücker M; Huntermann C; Bechara FG; Hoffmann K; Altmeyer P
    Skin Res Technol; 2004 Aug; 10(3):174-7. PubMed ID: 15225267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
    Kato T; Sato T; Kurokawa T; Nanjo H; Asanuma Y; Koyama K
    Transplantation; 2003 Nov; 76(9):1340-5. PubMed ID: 14627913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
    Tobari S; Ikeda Y; Takami H
    J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
    Weiss T; Fischer D; Hausmann D; Weiss C
    Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.